1660318540197 Number2

Pharma in review: trending stories 8/23/19

Aug. 23, 2019

Pfizer recalls migraine drug for possible microbial contamination

Pfizer has recalled two lots of migraine drug Relpax.

FDA warns Chinese co. for data integrity violations
The agency posted a warning letter to Ningbo Huize Commodity, an OTC drug manufacturer.
AbbVie’s Humira follow-up gets FDA nod

 A potential new blockbuster from AbbVie has gotten the go-ahead from the FDA.

FDA rejects potential jet lag treatment

Vanda Pharma announced that it has received a complete response letter from the FDA for Hetlioz.

Celgene wins key FDA ok ahead of BMS merger

The U.S. FDA has approved Celgene's rare bone marrow cancer drug, Inrebic.